1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6DFC3F6A20FA440B50025869A003AB2D1
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-disease-awareness-program-excellence-structure-timing?opendocument
18
19opendocument
203.226.72.118
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Product Launch Influences on Market Entry

Disease Awareness Program Excellence: Structure and Timing

ID: 5670


Features:

5 Info Graphics

14 Data Graphics

300+ Metrics

4 Narratives


Pages/Slides: 25


Published: 2021


Delivery Format: Online PDF Document


 

License Options:


Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from “Disease Awareness Program Excellence: Structure and Timing”

STUDY OVERVIEW

Disease state awareness campaigns have long been used by the pharma industry to reach patients and HCPs, particularly before a product is approved. These campaigns play a critical role in providing current trends in both disease understanding and treatment.

However, while some organizations have demonstrated strong acumen in their disease awareness programs, many struggle to effectively connect their campaigns to their targeted audiences and stumble on message timing.

Best Practices, LLC undertook this benchmarking research to identify how leading pharma and biotech companies are ensuring the effectiveness of their disease awareness program. The study presents an array of insights and benchmarks around the structure, timing, and activities for disease awareness programs.

KEY TOPICS

  • Disease awareness program structure
  • Disease awareness tactics
  • Timing of disease awareness activities

KEY METRICS
  • Which of the listed models best describes the organizational structure of your disease awareness program?
  • Please indicate whether each of the listed functions are involved in disease awareness programs; and which functions take a leading role in disease awareness programs
  • Does your company have a distinct group established that handles disease state awareness programs?
  • At what point does your company begin and end resourcing disease awareness efforts?
  • Please indicate the disease awareness activities you utilize, when you first begin each activity, and whether you use that activity in the subsequent periods listed
  • Please indicate, in order, your three most heavily used disease awareness activities

SAMPLE KEY FINDINGS
  • Activities and Alliances:
    • Most disease awareness efforts begin during clinical trials and end at launch +3 years
    • Disease awareness activities concentrated on launch year and launch -1 year
    • Unbranded websites, conference presentations/handouts, and MSL presentations are the most utilized disease awareness activities

METHODOLOGY

Best Practices, LLC engaged 30 leaders from 28 top life sciences organizations in this benchmarking research. Four executives participated in deep-dive operational interviews. Secondary research is occasionally provided for context.

Industries Profiled:
Pharmaceutical; Manufacturing; Biotech; Consumer Products; Diagnostic; Medical Device; Biopharmaceutical; Public Relations; Chemical; Health Care; Communications; Clinical Research; Laboratories


Companies Profiled:
AbbVie; Adamas Pharmaceuticals; AstraZeneca; Bayer; Biogen; Catalyst Pharmaceuticals; CSL Behring; Daiichi Sankyo; Eli Lilly and Company; EMD Serono; FleishmanHillard; Fresenius Medical Care; Genentech; Genzyme; Indivior; Merck KGaA; Merck Sharp & Dohme; Myovant Sciences; Nevakar; NexGen Healthcare; Novartis; Prometheus Laboratories; PruGen Pharmaceuticals; Sanofi; Teva Pharmaceutical Industries Ltd; Tokai Pharmaceuticals; Vertex Pharmaceuticals; ZS Pharma

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.